EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Stability Study of Fosfomycin in Elastomeric Pumps at 4 °C and 34 °C: Technical Bases for a Continuous Infusion Use for Outpatient Parenteral Antibiotic Therapy

Alessandra Manca iD, Alice Palermiti iD, Jacopo Mula iD, Jessica Cusato iD, Domenico Maiese, Marco Simiele, Amedeo De Nicolò iD, Antonio D'Avolio iD

Pharmaceutics · 19.09.2023 · 15 (9) · 2347

DOI: 10.3390/pharmaceutics15092347 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceutics, online erschienen am 19.09.2023. Verfasst von Alessandra Manca und 7 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Clinical Pharmacology and Pharmacogenetics, Department of Medical Sciences, Amedeo di Savoia Hospital, University of Turin, Corso Svizz…. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Fosfomycin acts against aerobic Gram−/+ bacteria by blocking the synthesis of peptidoglycan. Its use has been currently re-evaluated for intravenous administration for the treatment of systemic infections by multidrug-resistant bacteria. Concentration-/time-dependent activity has been suggested, with potential clinical advantages from prolonged or continuous infusion. Nevertheless, little is known about Fosfomycin stability in elastomeric pumps. The aim of the present work was stability investigation before administration at 4 °C and during administration at 34 °C.

Methods

InfectoFos® (InfectoPharm s.r.l., Milan, Italy) preparation for intravenous use in elastomeric pumps at 4 °C and 34 °C was analyzed following EMA guidelines for drug stability. Samples were analyzed with an ultra-high performance liquid chromatography coupled with tandem mass spectrometry method on a LX50® UHPLC system equipped with a QSight 220® (Perkin Elmer, Milan, Italy) tandem mass spectrometer.

Results

Fosfomycin in elastomeric preparation is stable for at least 5 days at a storage temperature of 4 °C and 34 °C.

Conclusions

The results suggest Fosfomycin eligibility for continuous infusion even in the context of outpatient parenteral antibiotic therapy. Therefore, this approach should be tested in clinical and pharmacokinetic studies, in order to evaluate the possible gains in the pharmacokinetic profile and the clinical effectiveness.

Schlagwörter

Stichwörter der Autor:innen

FosfomycinOPATUHPLCbridge therapystability

Autor:innen und Institutionen

  • Laboratory of Clinical Pharmacology and Pharmacogenetics, Department of Medical Sciences, Amedeo di Savoia Hospital, University of Turin, Corso Svizzera 164, 10149 Turin, Italy.
  • CoQua Lab s.r.l., Corso Svizzera 185 bis, 10149 Turin, Italy.

ORCID-Profile: Alessandra Manca, Alice Palermiti, Jacopo Mula, Jessica Cusato, Amedeo De Nicolò, Antonio D'Avolio

Zitieren

APA

Manca, A., Palermiti, A., Mula, J., Cusato, J., Maiese, D., Simiele, M., De Nicolò, A., & D'Avolio, A. (2023). Stability Study of Fosfomycin in Elastomeric Pumps at 4 °C and 34 °C: Technical Bases for a Continuous Infusion Use for Outpatient Parenteral Antibiotic Therapy. Pharmaceutics, 15(9), 2347. https://doi.org/10.3390/pharmaceutics15092347

Vancouver

Manca A, Palermiti A, Mula J, Cusato J, Maiese D, Simiele M, et al. Stability Study of Fosfomycin in Elastomeric Pumps at 4 °C and 34 °C: Technical Bases for a Continuous Infusion Use for Outpatient Parenteral Antibiotic Therapy. Pharmaceutics. 2023;15(9):2347. doi:10.3390/pharmaceutics15092347

BibTeX
@article{Manca2023,
  author = {Manca, Alessandra and Palermiti, Alice and Mula, Jacopo and Cusato, Jessica and Maiese, Domenico and Simiele, Marco and De Nicolò, Amedeo and D'Avolio, Antonio},
  title = {Stability Study of Fosfomycin in Elastomeric Pumps at 4 °C and 34 °C: Technical Bases for a Continuous Infusion Use for Outpatient Parenteral Antibiotic Therapy},
  journal = {Pharmaceutics},
  year = {2023},
  volume = {15},
  number = {9},
  pages = {2347},
  doi = {10.3390/pharmaceutics15092347}
}
Kostenlos starten →